{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT03502031",
            "orgStudyIdInfo": {
                "id": "NN-01"
            },
            "organization": {
                "fullName": "NephroNet, Inc.",
                "class": "OTHER"
            },
            "briefTitle": "Safety and Efficacy of Two Year of RAAS Alone or in Combination With Spironolactone Therapy",
            "officialTitle": "Safety and Efficacy of Maximally Tolerated RAAS Blockade and Spironolactone Therapy on Urinary Proteinuria and Progression of Type II Diabetic Nephropathy in African Americans and Other Patient Cohorts.",
            "acronym": "MRA-ACE",
            "therapeuticArea": [
                "Nephrology and Renal Diseases"
            ],
            "study": "safety-and-efficacy-of-two-year-of-raas-alone-or-in-combination-with-spironolactone-therapy"
        },
        "statusModule": {
            "statusVerifiedDate": "2022-10",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2018-10-01",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2022-10-01",
                "type": "ACTUAL"
            },
            "completionDateStruct": {
                "date": "2024-10-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2017-11-13",
            "studyFirstSubmitQcDate": "2018-04-10",
            "studyFirstPostDateStruct": {
                "date": "2018-04-18",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2022-10-27",
            "lastUpdatePostDateStruct": {
                "date": "2022-10-28",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR_INVESTIGATOR",
                "investigatorFullName": "James A. Tumlin, MD",
                "investigatorTitle": "Sponsor-Investigator",
                "investigatorAffiliation": "NephroNet, Inc."
            },
            "leadSponsor": {
                "name": "James A. Tumlin, MD",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "Nelson Kopyt, MD",
                    "class": "UNKNOWN"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "NephroNet proposes to examine whether combining Spironolactone with maximal RAAS blockade will further reduce urinary protein at one year and whether prolonged therapy (24 months) is able to slow the decline in GFR. Because of combination MRA and RAAS therapy significantly increases the risk for clinically significant hyperkalemia, we also plan to determine whether the addition of Patiromer to these patients facilitates the use of combination therapy and allows a larger proportion of diabetic patients the potential benefit of combination therapy on renal function."
        },
        "conditionsModule": {
            "conditions": [
                "Renal Insufficiency, Chronic",
                "Diabetic Nephropathy Type 2"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE4"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 72,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "RAAS alone",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "RAAS (Lisinopril, Enalapril, Perindopril, Losartan, and Valsartan taken each day at maximum tolerated dose that will different for each subject)",
                    "interventionNames": [
                        "Drug: Renin-Angiotensin (RAAS) alone"
                    ]
                },
                {
                    "label": "RAAS in Combination with Spironolactone",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "RAAS (Lisinopril, Enalapril, Perindopril, Losartan, and Valsartan taken each day at maximum tolerated dose that will different for each subject); Spironolactone taken each day at 25mg",
                    "interventionNames": [
                        "Drug: Renin-Angiotensin (RAAS) blockers in combination with Spironolactone"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Renin-Angiotensin (RAAS) alone",
                    "description": "maximal RAAS blockade alone for 24months.",
                    "armGroupLabels": [
                        "RAAS alone"
                    ],
                    "otherNames": [
                        "Lispril, Enalapril, Perindopril, Losarta, Valsar etc.,"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Renin-Angiotensin (RAAS) blockers in combination with Spironolactone",
                    "description": "maximal RAAS blockade alone or in combination with Spironolactone (25 mg) for 24 months.",
                    "armGroupLabels": [
                        "RAAS in Combination with Spironolactone"
                    ],
                    "otherNames": [
                        "Lisinopril, Enalapril, Perindopril, Losartan, Valsartan, or Spironolactone"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Combination Therapy - RAAS inhibition and Spironolactone to lower UP/Cr",
                    "description": "To determine whether combination therapy with maximall RAAS inhibition and Spironolactone is superior to RAAS inhibition alone in lowering the UP/Cr ratio at 12 months",
                    "timeFrame": "24 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Combination Therapy - RAAS inhibition and Spironolactone",
                    "description": "To determine whether combination therapy with maximally tolerated RAAS inhibition and Spironolactone is superior to RAAS inhibition alone in slowing the progression of renal disease as evidenced by changes in GFR",
                    "timeFrame": "24 months"
                },
                {
                    "measure": "Combination Therapy - RAAS inhibition and Spironolactone that develop hyperkalemia",
                    "description": "To determine the patients in the maximal RAAS blockade group and those receiving combination RAAS + Spironolactone therapy developing clinically significant hyperkalemia as defined as a serum K+ level greater than 5.5 meq/L. We will determine the percentage of patients that require \"Patiromer-Rescue\" for K+ \\> 5.5 meq/L and the percentage of patients maintained with serum K+ less than 5.5 meq/L",
                    "timeFrame": "12 months, 24 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Age above 18\n* Male or Female\n* Patients with Type II diabetes mellitus must be receiving oral agents or insulin injections at the time of randomization\n* All eligible patients will be on a stable, maximum to dose of an ACE or ARB for 2 weeks prior to randomization.\n* Note: The determination of m tolerated ACE-ARB therapy will be left to the discretion of the site princ\n* All eligible patientswill have hypertension targetblood pressur of \\< 140/90mm Hg.\n* Antihypertensiv therapy may be adjusted to achieve the target blood pressure prior to the time of randomization.\n* ACE or ARB therapy will be the primary antihypertensive therapy used for blood pressure control and will be titrthe highest tolerated dose to achieve a target blood pressure of \\<Patients requiring additional medications to achieve the target blood pressure will use antihypertensive agents that have neutral effects on urinary proteinuria (e.g. Hydralazine or lo Dihydropyridine calcium channel blockers etc.). CcThe final choice of additional medications will be left to the discretion of the site principal investigator (PI)\n* Patients with anurine protein to creatinine (UP/Cr) ratio that is mg/gm from the average of two historical value within one year prior to randomization will be considered eligible for study entry.\n* Patients with a baseline K+ of \\>5. X5 meq/l on maximum tolerated ACE-ARB therapy during the screening period can be treated with 8.4 grams of Patiromer for 7 days. If at the end of 7days the serum K+ is \\< 5.0 meq/liter the patient will be considered eligible to participate in the study. If at the end of 7 days the serum K+ \\>5.0 meq/l the dose of Patiromer can be increased to 16.8 grams. If at the end of 7 days the serum K+ is \\< 5.0 meq/L, the patient will be considered eligible for study entry. If after 7 days at the higher dose of Patiromer the serum K+ \\>5.0, the patient will be ineligible for study participation.\n* Patients with an estimated GFR by CK-Epi .73 m2\n* Female patients will be required to undergo routine birth control measures\n\nExclusion criteria:\n\n* Estimated GFR by MDRD20 mls/min/1.73 M2 using the CKD-Epi equation\n* Patients with serum K+ \\> 5.00 while taking 16.8/day of Patiromer\n* Patients with history of Type mellitus\n* Patients with HgbA\n* Pregnant or breast-feeding female patients\n* Female patients unwilling to receive estrogen or progesterone based birth control or are unwilling or unable to usconventional barrier birth control methods.\n* Patients with known allergy or intolerance tor Spironolactone therapy\n* Patients taking oral or IV digoxin\n* Patients receiving chronic steroids \\> 1oral Prednisone\n* Patient that do nohave minimum o eGFR determinations within 2 years prior to study randomization\n* Concurrent use of Amiloride, , Aliskerin, or other Aldosterone antagonists Patien receiving any of the above medications will be considered eligible for study participation after a wash-out",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "75 Years",
            "stdAges": [
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "James A Tumlin, MD",
                    "role": "CONTACT",
                    "phone": "770-490-9203",
                    "email": "jamestumlinmdnephronet@gmail.com"
                },
                {
                    "name": "Jeremy D Whitson, CCRA",
                    "role": "CONTACT",
                    "phone": "423-943-4265",
                    "email": "jwhitson@nephrynergy.com"
                }
            ],
            "locations": [
                {
                    "facility": "Georgia Nephrology Research Institute",
                    "status": "RECRUITING",
                    "city": "Lawrenceville",
                    "state": "Georgia",
                    "zip": "30046",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "James A Tumlin, MD",
                            "role": "CONTACT",
                            "phone": "770-490-9203",
                            "email": "jamestumlinmdnephronet@gmail.com"
                        },
                        {
                            "name": "Jeremy Whitson, CCRA",
                            "role": "CONTACT",
                            "phone": "423-943-4265",
                            "email": "jwhitson@nephro-synergy.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.95621,
                        "lon": -83.98796
                    }
                },
                {
                    "facility": "Nelson Kopyt, MD",
                    "status": "RECRUITING",
                    "city": "Bethlehem",
                    "state": "Pennsylvania",
                    "zip": "18017",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Stephanie Hanzl",
                            "role": "CONTACT",
                            "phone": "610-433-4100",
                            "phoneExt": "490",
                            "email": "shanzl@necresearch.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.62593,
                        "lon": -75.37046
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000007674",
                    "term": "Kidney Diseases"
                },
                {
                    "id": "D000051437",
                    "term": "Renal Insufficiency"
                },
                {
                    "id": "D000003928",
                    "term": "Diabetic Nephropathies"
                },
                {
                    "id": "D000051436",
                    "term": "Renal Insufficiency, Chronic"
                }
            ],
            "ancestors": [
                {
                    "id": "D000014570",
                    "term": "Urologic Diseases"
                },
                {
                    "id": "D000052776",
                    "term": "Female Urogenital Diseases"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000052801",
                    "term": "Male Urogenital Diseases"
                },
                {
                    "id": "D000048909",
                    "term": "Diabetes Complications"
                },
                {
                    "id": "D000003920",
                    "term": "Diabetes Mellitus"
                },
                {
                    "id": "D000004700",
                    "term": "Endocrine System Diseases"
                },
                {
                    "id": "D000002908",
                    "term": "Chronic Disease"
                },
                {
                    "id": "D000020969",
                    "term": "Disease Attributes"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M10698",
                    "name": "Kidney Diseases",
                    "asFound": "Nephropathy",
                    "relevance": "HIGH"
                },
                {
                    "id": "M26717",
                    "name": "Renal Insufficiency, Chronic",
                    "asFound": "Renal Insufficiency, Chronic",
                    "relevance": "HIGH"
                },
                {
                    "id": "M26718",
                    "name": "Renal Insufficiency",
                    "asFound": "Renal Insufficiency",
                    "relevance": "HIGH"
                },
                {
                    "id": "M20559",
                    "name": "Disease Progression",
                    "relevance": "LOW"
                },
                {
                    "id": "M14368",
                    "name": "Proteinuria",
                    "relevance": "LOW"
                },
                {
                    "id": "M7123",
                    "name": "Diabetic Nephropathies",
                    "asFound": "Diabetic Nephropathy",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17319",
                    "name": "Urologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M27095",
                    "name": "Male Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M7115",
                    "name": "Diabetes Mellitus",
                    "relevance": "LOW"
                },
                {
                    "id": "M26004",
                    "name": "Diabetes Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M7862",
                    "name": "Endocrine System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M6147",
                    "name": "Chronic Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "M22700",
                    "name": "Disease Attributes",
                    "relevance": "LOW"
                },
                {
                    "id": "T1303",
                    "name": "Chronic Graft Versus Host Disease",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                },
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000019808",
                    "term": "Losartan"
                },
                {
                    "id": "D000068756",
                    "term": "Valsartan"
                },
                {
                    "id": "D000004656",
                    "term": "Enalapril"
                },
                {
                    "id": "D000015773",
                    "term": "Enalaprilat"
                },
                {
                    "id": "D000017706",
                    "term": "Lisinopril"
                },
                {
                    "id": "D000020913",
                    "term": "Perindopril"
                },
                {
                    "id": "D000013148",
                    "term": "Spironolactone"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000959",
                    "term": "Antihypertensive Agents"
                },
                {
                    "id": "D000047228",
                    "term": "Angiotensin II Type 1 Receptor Blockers"
                },
                {
                    "id": "D000057911",
                    "term": "Angiotensin Receptor Antagonists"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000000889",
                    "term": "Anti-Arrhythmia Agents"
                },
                {
                    "id": "D000000451",
                    "term": "Mineralocorticoid Receptor Antagonists"
                },
                {
                    "id": "D000006727",
                    "term": "Hormone Antagonists"
                },
                {
                    "id": "D000006730",
                    "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000062865",
                    "term": "Diuretics, Potassium Sparing"
                },
                {
                    "id": "D000004232",
                    "term": "Diuretics"
                },
                {
                    "id": "D000045283",
                    "term": "Natriuretic Agents"
                },
                {
                    "id": "D000000806",
                    "term": "Angiotensin-Converting Enzyme Inhibitors"
                },
                {
                    "id": "D000011480",
                    "term": "Protease Inhibitors"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                },
                {
                    "id": "D000002316",
                    "term": "Cardiotonic Agents"
                },
                {
                    "id": "D000020011",
                    "term": "Protective Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M15943",
                    "name": "Spironolactone",
                    "asFound": "Pacing",
                    "relevance": "HIGH"
                },
                {
                    "id": "M301",
                    "name": "Valsartan",
                    "asFound": "Urinary",
                    "relevance": "HIGH"
                },
                {
                    "id": "M21701",
                    "name": "Losartan",
                    "asFound": "Core",
                    "relevance": "HIGH"
                },
                {
                    "id": "M19924",
                    "name": "Lisinopril",
                    "asFound": "Read",
                    "relevance": "HIGH"
                },
                {
                    "id": "M22648",
                    "name": "Perindopril",
                    "asFound": "Policy",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7822",
                    "name": "Enalapril",
                    "asFound": "RSV",
                    "relevance": "HIGH"
                },
                {
                    "id": "M18330",
                    "name": "Enalaprilat",
                    "asFound": "RSV",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4277",
                    "name": "Antihypertensive Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4132",
                    "name": "Angiotensin II",
                    "relevance": "LOW"
                },
                {
                    "id": "M289354",
                    "name": "Giapreza",
                    "relevance": "LOW"
                },
                {
                    "id": "M4135",
                    "name": "Angiotensinogen",
                    "relevance": "LOW"
                },
                {
                    "id": "M25789",
                    "name": "Angiotensin II Type 1 Receptor Blockers",
                    "relevance": "LOW"
                },
                {
                    "id": "M28916",
                    "name": "Angiotensin Receptor Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M4213",
                    "name": "Anti-Arrhythmia Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M3797",
                    "name": "Mineralocorticoid Receptor Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M11871",
                    "name": "Mineralocorticoids",
                    "relevance": "LOW"
                },
                {
                    "id": "M9789",
                    "name": "Hormones",
                    "relevance": "LOW"
                },
                {
                    "id": "M9788",
                    "name": "Hormone Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M7411",
                    "name": "Diuretics",
                    "relevance": "LOW"
                },
                {
                    "id": "M30025",
                    "name": "Diuretics, Potassium Sparing",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M4134",
                    "name": "Angiotensin-Converting Enzyme Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M19609",
                    "name": "HIV Protease Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M14343",
                    "name": "Protease Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M5572",
                    "name": "Cardiotonic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M21869",
                    "name": "Protective Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "NaAg",
                    "name": "Natriuretic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "AnAg",
                    "name": "Antihypertensive Agents"
                },
                {
                    "abbrev": "AnArAg",
                    "name": "Anti-Arrhythmia Agents"
                },
                {
                    "abbrev": "CaAg",
                    "name": "Cardiotonic Agents"
                },
                {
                    "abbrev": "VaCoAg",
                    "name": "Vasoconstrictor Agents"
                },
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                }
            ]
        }
    },
    "hasResults": false
}